MEREU, ELISABETTA
MEREU, ELISABETTA
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas
2018-01-01 Osella-Abate, Simona; Mereu, Elisabetta; Pellegrino, Elisa; Bergaggio, Elisa; Ribero, Simone; Bertero, Luca; Lisa, Francesco; Fierro, Maria Teresa; Papotti, Mauro Giulio; Piva, Roberto*
Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myeloma
2026-01-01 Cumerlato, Michela; Maccagno, Monica; Labrador, María; Luciano, Beatrice; Mereu, Elisabetta; Porro, Mariangela; Bandini, Cecilia; Furlan, Mattia; Maisano, Domenico; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Tamburrini, Annalaura; Anselmi, Francesca; Porporato, Paolo Ettore; Oliviero, Salvatore; Bruno, Benedetto; Morelli, Eugenio; Munshi, Nikhil; Piva, Roberto
Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells
2021-01-01 Cauda V.; Xu T.T.; Nunes I.; Mereu E.; Villata S.; Bergaggio E.; Labrador M.; Limongi T.; Susa F.; Chiodoni A.; Cumerlato M.; Rosso G.; Stefania R.; Piva R.
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma
2024-01-01 Noemi Puccio; Gloria Manzotti; Mereu E; Torricelli F; Ronchetti D; Cumerlato M; Craparotta I; Di Rito L; Bolis M; Traini V; Manicardi V; Fragliasso V; Torrente Y; Amodio N; Bolli N; Taiana E; Ciarrocchi A; Piva R; Neri A
Common genomic and transcriptomic signatures in Richter transformation highlight druggable vulnerabilities and guide drug repurposing strategies
2026-01-01 Vallone F.E.; Omezzolli G.; Micillo M.; Iannello A.; Ferrero G.; Berrino E.; Mereu E.; Bellomo S.E.; Rosso E.; Di Napoli A.; Jaksic O.; Molinaro L.; Marchio C.; Piva R.; Cordero F.; Deaglio S.; Vaisitti T.
CRISPR activation screen identifies MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma
2023-01-01 María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Elisabetta Mereu, Tina Paradzik, Cecilia Bandini, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri.
CRISPR activation screen identifies novel drivers of proteasome inhibitor resistance in multiple myeloma.
2025-01-01 Mariangela Porro, María Labrador Granados, Elisabetta Mereu, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri, Roberto Piva.
Dual Targeting of IDH2 and the Ubiquitin-Proteasome System Reveals a Functional Vulnerability in Breast Cancer Models
2026-01-01 Gharari, Nariman; Mereu, Elisabetta; Luciano, Beatrice; Heidari, Bahareh; Mader, Sylvie; Piva, Roberto
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines
2023-01-01 Mereu, Elisabetta; Abbo, Damiano; Paradzik, Tina; Cumerlato, Michela; Bandini, Cecilia; Labrador, Maria; Maccagno, Monica; Ronchetti, Domenica; Manicardi, Veronica; Neri, Antonino; Piva, Roberto
Extraction Bottleneck in the Diagnosis of SARS-CoV-2: Evaluation of an Alternative Protocol Derived from Veterinary Use
2023-01-01 Bottino, Paolo; Zanotto, Elisa; Sidoti, Francesca; Pastrone, Lisa; Piva, Roberto; Mereu, Elisabetta; Costa, Cristina; Cavallo, Rossana
Functional screenings converge on MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma
2022-01-01 María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Mereu E., Paradzik T., Cecilia Bandini, Cumerlato M., Donati B., Manicardi V., Ronchetti D., Ciarrocchi A., Antonino Neri, Roberto Piva
Genetic and Drug Screenings Revealed New Synthetic Lethal Interactions to Proteasome Inhibitors in Multiple Myeloma
2024-01-01 Michela Cumerlato, Elisabetta Mereu, Cecilia Bandini, Tina Paradzik, Damiano Abbo, María Labrador Granados, Monica Maccagno, Mattia D’Agostino, Antonino Neri, Roberto Piva.
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma
2012-01-01 Agnelli, Luca; Mereu, Elisabetta; Pellegrino, Elisa; Limongi, Tania; Kwee, Ivo; Bergaggio, Elisa; Ponzoni, Maurilio; Zamò, Alberto; Iqbal, Javeed; Piccaluga, Pier Paolo; Neri, Antonino; Chan, Wing C.; Pileri, Stefano; Bertoni, Francesco; Inghirami, Giorgio; Piva, Roberto; on behalf of the European T-Cell Lymphoma Study Group;
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts
2016-01-01 Scarfo', Irene; Pellegrino, Elisa; Mereu, Elisabetta; Kwee, Ivo; Agnelli, Luca; Bergaggio, Elisa; Garaffo, Giulia; Vitale, Nicoletta; Caputo, Manuel; Machiorlatti, Rodolfo; Circosta, Paola; Abate, Francesco; Barreca, Antonella; Novero, Domenico; Mathew, Susan; Rinaldi, Andrea; Tiacci, Enrico; Serra, Sara; Deaglio, Silvia; Neri, Antonino; Falini, Brunanagelo; Rabadan, Raul; Bertoni, Francesco; Inghirami, Giorgio; Piva, Roberto
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies
2019-01-01 Bergaggio, Elisa; Riganti, Chiara; Garaffo, Giulia; Vitale, Nicoletta; Mereu, Elisabetta; Bandini, Cecilia; Pellegrino, Elisa; Pullano, Verdiana; Omedè, Paola; Todoerti, Katia; Cascione, Luciano; Audrito, Valentina; Riccio, Anna; Rossi, Antonio; Bertoni, Francesco; Deaglio, Silvia; Neri, Antonino; Palumbo, Antonio; Piva, Roberto
LSD1 inhibition increases DNA damage and enhances proteasome inhibition sensitivity in multiple myeloma and other B-cell malignancies
2022-01-01 Cecilia Bandini, María Labrador Granados, Mereu E., Paradzik T., Cumerlato M., Federico Oreglia, Giada Cipollina, Lorenzo Prever, Sauta E., Veronica Manicardi, Elisa Taiana, Domenica Ronchetti, Ferrero S., Francesca Gay, Alessandra Larocca, Giorgio Merlo, Alessia Ciarrocchi, Antonino Neri, Roberto Piva
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma
2023-01-01 Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma
2026-01-01 Labrador, María; Cozzubbo, Sara; Porro, Mariangela; Cumerlato, Michela; Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Donati, Benedetta; Manicardi, Veronica; Ronchetti, Domenica; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Bruno, Benedetto; Ciarrocchi, Alessia; Chatr-Aryamontri, Andrew; Neri, Antonino; Morelli, Eugenio; Piva, Roberto
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22
2016-01-01 Arruga, F; Gizdic, B; Bologna, C; Cignetto, S; Buonincontri, R; Serra, S; Vaisitti, T; Vitale, N; Garaffo, G; Mereu, E; Diop, F; Neri, F; Coscia, M; Allan, JN; Piva, R; Oliviero, S; Furman, RR; Rossi, D; Gaidano, G; Deaglio, S
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22
2017-01-01 Francesca, Arruga; Branimir, Gizdic; Bologna, Cinzia; Cignetto, Simona; Buonincontri, Roberta; Serra, Sara; Vaisitti, Tiziana; Katiuscia, Gizzi; Vitale, Nicoletta; Garaffo, Giulia; Mereu, Elisabetta; Fary, Diop; Francesco, Neri; Coscia, Marta; John, Allan; Piva, Roberto; Oliviero, Salvatore; Richard, Furman; Davide, Rossi; Gianluca, Gaidano; Deaglio, Silvia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas | 2018 | Osella-Abate, Simona; Mereu, Elisabetta; Pellegrino, Elisa; Bergaggio, Elisa; Ribero, Simone; Bertero, Luca; Lisa, Francesco; Fierro, Maria Teresa; Papotti, Mauro Giulio; Piva, Roberto* | |
| Bedaquiline amplifies proteasome inhibitor efficacy and overcomes resistance in multiple myeloma | 2026 | Cumerlato, Michela; Maccagno, Monica; Labrador, María; Luciano, Beatrice; Mereu, Elisabetta; Porro, Mariangela; Bandini, Cecilia; Furlan, Mattia; Maisano, Domenico; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Tamburrini, Annalaura; Anselmi, Francesca; Porporato, Paolo Ettore; Oliviero, Salvatore; Bruno, Benedetto; Morelli, Eugenio; Munshi, Nikhil; Piva, Roberto | |
| Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells | 2021 | Cauda V.; Xu T.T.; Nunes I.; Mereu E.; Villata S.; Bergaggio E.; Labrador M.; Limongi T.; Susa F.; Chiodoni A.; Cumerlato M.; Rosso G.; Stefania R.; Piva R. | |
| Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma | 2024 | Noemi Puccio; Gloria Manzotti; Mereu E; Torricelli F; Ronchetti D; Cumerlato M; Craparotta I; Di Rito L; Bolis M; Traini V; Manicardi V; Fragliasso V; Torrente Y; Amodio N; Bolli N; Taiana E; Ciarrocchi A; Piva R; Neri A | |
| Common genomic and transcriptomic signatures in Richter transformation highlight druggable vulnerabilities and guide drug repurposing strategies | 2026 | Vallone F.E.; Omezzolli G.; Micillo M.; Iannello A.; Ferrero G.; Berrino E.; Mereu E.; Bellomo S.E.; Rosso E.; Di Napoli A.; Jaksic O.; Molinaro L.; Marchio C.; Piva R.; Cordero F.; Deaglio S.; Vaisitti T. | |
| CRISPR activation screen identifies MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma | 2023 | María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Elisabetta Mereu, Tina Paradzik, Cecilia Bandini, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri. | |
| CRISPR activation screen identifies novel drivers of proteasome inhibitor resistance in multiple myeloma. | 2025 | Mariangela Porro, María Labrador Granados, Elisabetta Mereu, Michela Cumerlato, Benedetta Donati, Veronica Manicardi, Domenica Ronchetti, Alessia Ciarrocchi, Antonino Neri, Roberto Piva. | |
| Dual Targeting of IDH2 and the Ubiquitin-Proteasome System Reveals a Functional Vulnerability in Breast Cancer Models | 2026 | Gharari, Nariman; Mereu, Elisabetta; Luciano, Beatrice; Heidari, Bahareh; Mader, Sylvie; Piva, Roberto | |
| Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines | 2023 | Mereu, Elisabetta; Abbo, Damiano; Paradzik, Tina; Cumerlato, Michela; Bandini, Cecilia; Labrador, Maria; Maccagno, Monica; Ronchetti, Domenica; Manicardi, Veronica; Neri, Antonino; Piva, Roberto | |
| Extraction Bottleneck in the Diagnosis of SARS-CoV-2: Evaluation of an Alternative Protocol Derived from Veterinary Use | 2023 | Bottino, Paolo; Zanotto, Elisa; Sidoti, Francesca; Pastrone, Lisa; Piva, Roberto; Mereu, Elisabetta; Costa, Cristina; Cavallo, Rossana | |
| Functional screenings converge on MDM2 as a modulator of proteasome inhibitor resistance in multiple myeloma | 2022 | María Labrador Granados, Sara Cozzubbo, Mariangela Porro, Mereu E., Paradzik T., Cecilia Bandini, Cumerlato M., Donati B., Manicardi V., Ronchetti D., Ciarrocchi A., Antonino Neri, Roberto Piva | |
| Genetic and Drug Screenings Revealed New Synthetic Lethal Interactions to Proteasome Inhibitors in Multiple Myeloma | 2024 | Michela Cumerlato, Elisabetta Mereu, Cecilia Bandini, Tina Paradzik, Damiano Abbo, María Labrador Granados, Monica Maccagno, Mattia D’Agostino, Antonino Neri, Roberto Piva. | |
| Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma | 2012 | Agnelli, Luca; Mereu, Elisabetta; Pellegrino, Elisa; Limongi, Tania; Kwee, Ivo; Bergaggio, Elisa; Ponzoni, Maurilio; Zamò, Alberto; Iqbal, Javeed; Piccaluga, Pier Paolo; Neri, Antonino; Chan, Wing C.; Pileri, Stefano; Bertoni, Francesco; Inghirami, Giorgio; Piva, Roberto; on behalf of the European T-Cell Lymphoma Study Group; | |
| Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts | 2016 | Scarfo', Irene; Pellegrino, Elisa; Mereu, Elisabetta; Kwee, Ivo; Agnelli, Luca; Bergaggio, Elisa; Garaffo, Giulia; Vitale, Nicoletta; Caputo, Manuel; Machiorlatti, Rodolfo; Circosta, Paola; Abate, Francesco; Barreca, Antonella; Novero, Domenico; Mathew, Susan; Rinaldi, Andrea; Tiacci, Enrico; Serra, Sara; Deaglio, Silvia; Neri, Antonino; Falini, Brunanagelo; Rabadan, Raul; Bertoni, Francesco; Inghirami, Giorgio; Piva, Roberto | |
| IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies | 2019 | Bergaggio, Elisa; Riganti, Chiara; Garaffo, Giulia; Vitale, Nicoletta; Mereu, Elisabetta; Bandini, Cecilia; Pellegrino, Elisa; Pullano, Verdiana; Omedè, Paola; Todoerti, Katia; Cascione, Luciano; Audrito, Valentina; Riccio, Anna; Rossi, Antonio; Bertoni, Francesco; Deaglio, Silvia; Neri, Antonino; Palumbo, Antonio; Piva, Roberto | |
| LSD1 inhibition increases DNA damage and enhances proteasome inhibition sensitivity in multiple myeloma and other B-cell malignancies | 2022 | Cecilia Bandini, María Labrador Granados, Mereu E., Paradzik T., Cumerlato M., Federico Oreglia, Giada Cipollina, Lorenzo Prever, Sauta E., Veronica Manicardi, Elisa Taiana, Domenica Ronchetti, Ferrero S., Francesca Gay, Alessandra Larocca, Giorgio Merlo, Alessia Ciarrocchi, Antonino Neri, Roberto Piva | |
| Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma | 2023 | Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto | |
| MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma | 2026 | Labrador, María; Cozzubbo, Sara; Porro, Mariangela; Cumerlato, Michela; Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Donati, Benedetta; Manicardi, Veronica; Ronchetti, Domenica; D'Agostino, Mattia; Larocca, Alessandra; Gay, Francesca; Bruno, Benedetto; Ciarrocchi, Alessia; Chatr-Aryamontri, Andrew; Neri, Antonino; Morelli, Eugenio; Piva, Roberto | |
| Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22 | 2016 | Arruga, F; Gizdic, B; Bologna, C; Cignetto, S; Buonincontri, R; Serra, S; Vaisitti, T; Vitale, N; Garaffo, G; Mereu, E; Diop, F; Neri, F; Coscia, M; Allan, JN; Piva, R; Oliviero, S; Furman, RR; Rossi, D; Gaidano, G; Deaglio, S | |
| Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22 | 2017 | Francesca, Arruga; Branimir, Gizdic; Bologna, Cinzia; Cignetto, Simona; Buonincontri, Roberta; Serra, Sara; Vaisitti, Tiziana; Katiuscia, Gizzi; Vitale, Nicoletta; Garaffo, Giulia; Mereu, Elisabetta; Fary, Diop; Francesco, Neri; Coscia, Marta; John, Allan; Piva, Roberto; Oliviero, Salvatore; Richard, Furman; Davide, Rossi; Gianluca, Gaidano; Deaglio, Silvia |